Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6301 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
79-21        IXEMPRA KIT R-Pharm US LLC Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-22        Astomin OrphanPacific, Inc. (株式会社オーファンパシフィック) Original drug not imported to China Approved in Japan The 79th Batch of Reference Listed Drugs
79-23        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-24        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-25        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-26        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-27        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-28        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-29        HYSINGLA ER Purdue Pharma LP Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-30        Penles Nitto Denko Corporation Original drug not imported to China Approved in Japan The 79th Batch of Reference Listed Drugs